These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32249633)

  • 1. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
    Baccon-Sollier PL; Malki Y; Maye M; Ali LMA; Lichon L; Cuq P; Vincent LA; Masurier N
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):935-949. PubMed ID: 32249633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
    Bellet V; Lichon L; Arama DP; Gallud A; Lisowski V; Maillard LT; Garcia M; Martinez J; Masurier N
    Eur J Med Chem; 2017 Jan; 125():1225-1234. PubMed ID: 27871038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.
    Gallud A; Vaillant O; Maillard LT; Arama DP; Dubois J; Maynadier M; Lisowski V; Garcia M; Martinez J; Masurier N
    Eur J Med Chem; 2014 Mar; 75():382-90. PubMed ID: 24561668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
    Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
    Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
    Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
    Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M
    Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.
    Xie M; Lapidus RG; Sadowska M; Edelman MJ; Hosmane RS
    Bioorg Med Chem; 2016 Jun; 24(12):2595-602. PubMed ID: 27134120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxicity of novel imidazo[4,5-d]azepine compounds derived from marine natural product ceratamine A.
    Pan X; Tao L; Ji M; Chen X; Liu Z
    Bioorg Med Chem Lett; 2018 Mar; 28(5):866-868. PubMed ID: 29433924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.
    Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y
    Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
    Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
    Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor compounds identification from gossypol Groebke imidazopyridine product.
    Wang W; Lu Y; Chen E; Shen K; Li J
    Bioorg Chem; 2021 Sep; 114():105146. PubMed ID: 34328859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
    Fray MJ; Bull DJ; Cooper K; Parry MJ; Stefaniak MH
    J Med Chem; 1995 Sep; 38(18):3524-35. PubMed ID: 7658439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
    Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.
    Meenakshisundaram S; Manickam M; Pillaiyar T
    Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900011. PubMed ID: 31596021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
    Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, Antitumor Activity and NMR-Based Metabolomics of Novel Amino Substituted Tetracyclic Imidazo[4,5-b]Pyridine Derivatives.
    Perin N; Lončar B; Kadić M; Kralj M; Starčević K; Carvalho RA; Jarak I; Hranjec M
    ChemMedChem; 2024 Sep; 19(17):e202300633. PubMed ID: 38757872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.